4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-022787
Chief Financial Officer bought 900 shares at $6.42 ($5,778)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2017-03-23 | Purchase | +900 | $6.42 | $5,778 | 12,800 | D |
| Open-market purchases · 900 sh · avg $6.42 · $5,778 | |||||||
Loading xslF345X03/doc4.xml…